本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Summit Therapeutics PLC

17.55
+0.55003.24%
盤後17.700.1500+0.85%19:58 EDT
成交量:427.81萬
成交額:7,493.63萬
市值:140.01億
市盈率:-15.70
高:17.70
開:17.20
低:17.14
收:17.00
52周最高:29.23
52周最低:12.07
股本:7.98億
流通股本:1.52億
量比:0.56
換手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
淨資產收益率:-192.50%
總資產收益率:-101.61%
市淨率:22.22
市盈率(LYR):-12.15

資料載入中...

2020/11/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/24

重要事件披露

8-K/A [Amend] - Current report
2020/11/23

重要事件披露

8-K - Current report
2020/11/16

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/11/13

重要事件披露

8-K - Current report
2020/11/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/06

重要事件披露

8-K - Current report
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/05

重要事件披露

8-K - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/09/28

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/28

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/18

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities